These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 2310294)

  • 21. [Various problems on refractory peptic ulcers; progress of drug therapy and changes in the concept of peptic ulcer].
    Ishimori A; Kawamura T
    Nihon Rinsho; 1988 Jan; 46(1):146-51. PubMed ID: 3373747
    [No Abstract]   [Full Text] [Related]  

  • 22. [Drug therapy of peptic ulcer. What is coming up?].
    Müller P; Dammann HG; Simon B; Kommerell B
    Leber Magen Darm; 1987 Feb; 17(1):50-4. PubMed ID: 3104707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of two new therapies for peptic ulcer disease: omeprazole and the prostaglandin analogues.
    McColl KE
    Dig Dis; 1988; 6(2):65-75. PubMed ID: 3129220
    [No Abstract]   [Full Text] [Related]  

  • 24. [New prostaglandin derivatives--progress in ulcer therapy?].
    Schepp W
    Fortschr Med; 1986 Dec; 104(3):913-7. PubMed ID: 2881863
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug therapy of peptic ulcer].
    Siurala M
    Duodecim; 1978; 94(12):802-9. PubMed ID: 28938
    [No Abstract]   [Full Text] [Related]  

  • 26. [Aggression or protection of the gastric mucosa in the pathogenesis of peptic ulcer and prostaglandins and the problem of treatment].
    Rybicka J
    Pol Arch Med Wewn; 1983 Oct; 70(4):189-96. PubMed ID: 6364053
    [No Abstract]   [Full Text] [Related]  

  • 27. [The mechanism of action of new drugs in ulcer therapy].
    Simon B; Fromm T; Kather H; Kommerell B
    Verh Dtsch Ges Inn Med; 1978; (84):984-7. PubMed ID: 742166
    [No Abstract]   [Full Text] [Related]  

  • 28. [Gastroduodenal ulcer pathology and prostaglandins].
    Bellanger J; Pointereau-Bellanger A
    Ann Gastroenterol Hepatol (Paris); 1987 May; 23(3):129-34. PubMed ID: 3113323
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of 16, 16-dimethylprostaglandin E2 on the electrolyte barrier of the stomach in patients with peptic ulcer].
    Orzechowska R
    Pol Arch Med Wewn; 1983 Sep; 70(3):93-9. PubMed ID: 6657495
    [No Abstract]   [Full Text] [Related]  

  • 30. [Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer].
    Grigor'ev PIa; Isakov VA
    Sov Med; 1991; (3):39-43. PubMed ID: 1909055
    [No Abstract]   [Full Text] [Related]  

  • 31. Protective and therapeutic effects of gastrointestinal prostaglandins. Enprostil: a new modality. Proceedings of a symposium. November 13-14, 1985, Toronto, Canada.
    Am J Med; 1986 Aug; 81(2A):1-88. PubMed ID: 3092649
    [No Abstract]   [Full Text] [Related]  

  • 32. Are prostaglandins truly "cytoprotective"?
    Morris GP
    J Clin Gastroenterol; 1986 Jun; 8(3 Pt 2):326-30. PubMed ID: 3760515
    [No Abstract]   [Full Text] [Related]  

  • 33. [Peptic ulcer--advances in drug therapy].
    Gütz HJ
    Z Arztl Fortbild (Jena); 1990; 84(16):811-3. PubMed ID: 1977243
    [No Abstract]   [Full Text] [Related]  

  • 34. Rioprostil: a new prostaglandin for treatment of peptic ulcer disease and NSAID-induced digestive lesions. Proceedings of an international symposium. Wiesbaden, 11-13 June 1987.
    Scand J Gastroenterol Suppl; 1989; 164():1-253. PubMed ID: 2510250
    [No Abstract]   [Full Text] [Related]  

  • 35. Advances in the treatment of peptic ulcer disease.
    Camara DS
    Compr Ther; 1987 Aug; 13(8):13-6. PubMed ID: 2887333
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of E2 prostaglandins on gastric secretion and gastrointestinal mucosa.
    Johansson C; Kollberg B
    Scand J Gastroenterol Suppl; 1980; 58():93-7. PubMed ID: 6988944
    [No Abstract]   [Full Text] [Related]  

  • 37. Newer antisecretory agents for peptic ulcer.
    Somerville KW; Langman MJ
    Drugs; 1983 Mar; 25(3):315-30. PubMed ID: 6133734
    [No Abstract]   [Full Text] [Related]  

  • 38. Colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN
    S Afr Med J; 1986 Jul; 70(1):31-3. PubMed ID: 3523793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Peptic ulcer. New H2 blockers, prostaglandins, benzimidazoles].
    Gugler R
    Fortschr Med; 1987 Apr; 105(10):197-201. PubMed ID: 3108126
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacologic options for the control of peptic ulcer disease.
    Levine JB
    Adv Intern Med; 1984; 30():425-47. PubMed ID: 6152108
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.